Why Natus Medical Stock Surged Today

ByJeffrey J. Baker

Apr 29, 2022 #Applications That Respect Mental Health, #Collin College Nursing Health Insurance, #Cover Nevada Health Insurance, #Desert Hills Behavioral Health, #Epoch Health Care Ma, #Foreign Service Health, #Health 4th Grade Monthly Publications, #Health Ads Fitness Peoducts, #Health Affects For Natural Diasters, #Health And Medicine Topic, #Health And Nutrition Clarksville, #Health B Unit 6 Review, #Health Benefits Eating Basil, #Health Benefits Greeon Olives, #Health Benefits To Chaga Mushroom, #Health Care Products Qatar, #Health Care Quality Improvement Heinz, #Health Care Site:Quora, #Health Chick Fil A, #Health Club Suzhou China, #Health Compliancy Questions, #Health Insurance Provider California, #Health Insurance Quote Assisted, #High Agility Health Care, #Home Health Agency In Houston, #Home Health Aide Suffolk, #Home Health Care Joliet Il, #Leaf Health Class, #Linda Jasso Health Information Management, #Natural Health Grover Beach, #Natural Supplement For Lung Health, #Navicent Health Inquicker.Com, #Nurse Back To Health Synonym, #Optimal Health Tsfl, #Optimizing Health On Adderall, #Pubic Health Major Uf, #Public Health Careers In Ct, #Public Health Nurse Naalehu, #Public Health Policy Breif, #Public Health Riverside County, #Thesis Stament About Health, #Titan Quest Increase Health Regeneration, #Topper Health Manzella, #Unity Health Dental Care, #What Does Health Management Do, #What Is Adapt Health, #Who Heads Up Husky Health, #Who Health Definition 1948, #Wrap Around Health Insurance Plan, #Ws 1099 Health Care

What happened

Shares of Natus Medical (NTUS 0.15%) jumped 28.6% on Monday after the healthcare device maker struck a deal to be acquired by an affiliate of investment firm ArchiMed. 

So what

The deal values Natus at roughly $1.2 billion. If completed, shareowners would receive $33.50 in cash for each Natus share they own. That’s 29% above the stock’s closing price on Thursday.

Natus chairman Joshua Levine said in a press release, “The sale of Natus to ArchiMed will provide our shareholders with immediate and substantial cash value, as well as a compelling premium, and the board has unanimously agreed that this transaction is in the best interests of our shareholders.” 

Doctors are reviewing brain scans on computers.

Image source: Getty Images.

The transaction is projected to close in the third quarter, subject to regulatory and shareholder approval. However, the deal gives Natus the option to solicit bids from other potential acquirers until as late as May 22. Natus plans to keep negotiations with other suitors confidential unless it receives a better offer than ArchiMed’s.

Now what

Natus specializes in medical devices and software that diagnose and treat the brain and nervous system. Demand for its tools is rising, with the global neurodiagnostics market forecast to nearly double to $12.9 billion by 2030, according to Allied Market Research. 

CEO Thomas Sullivan said the company’s commitment to advancing patient care in its key markets would remain firm under ArchiMed’s umbrella. “ArchiMed’s mix of operational, medical, scientific, and financial expertise will help us continue our mission to serve our customers,” Sullivan said.